Search the Newsreel

AXSM|Axsome Therapeutics Inc|Price:213.630|Chg%:-1.030

MaxLinear Inc (MXL) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 57/100

MaxLinear Inc (MXL) saw its stock rise by 3.1% to $76.64, but GuruFocus's GF Value™ indicates the stock is significantly overvalued by 285.2%, with a fair value of $19.90. The company's GF Score™ is 57/100, reflecting average performance, with strong financial strength but poor …

Barclays PLC discloses 1.23M Axiom Intelligence (AXIN) shares on Schedule 13G

MarketAxess Stock And Other Income Names Riding The Treasury Yield Revival

This article examines three stocks—MarketAxess Holdings (MKTX), WisdomTree (WT), and Northern Trust (NTRS)—that are exposed to the current environment of rising U.S. Treasury yields and increased government bond issuance. It discusses how each company stands to benefit or face challenges from these trends, highlighting …

Earnings call transcript: AVAX One posts Q2 2026 revenue surge, shares rise after hours

Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue

AVAX One revenue up 523% in Q2 2026; issues full-year guidance

AVAX One Q2 Results: Revenue Up 460% YoY To $2.8 Million

Newsmax Inc. Reports Q2 2026 Financials with Decline in Assets and Settlement Liabilities

Newsmax Inc. filed its Q2 2026 financial report, showing a decrease in total assets to $230.3 million from $239.8 million at the end of 2025, alongside a significant reduction in settlement liabilities. Despite the asset decline, cash and cash equivalents increased, and stockholders' equity …

Axogen (AXGN) Q2 2026 Earnings Call Transcript

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum. The firm's total Q2 turnover reached £8.4 billion, marking a 5% increase year-over-year at constant exchange rates (CER), while Core operating profit climbed …

Transcript : AXISCADES Technologies Limited, Q1 2027 Earnings Call, Aug 13, 2026

ITHAX Acquisition Corp. III Submits Q2 2026 SEC 10-Q Filing Detailing Financial Performance

ITHAX Acquisition Corp. III, a blank check SPAC, filed its Q2 2026 Form 10-Q with the SEC, outlining its financial performance. Key highlights include a trust account balance of $234.3 million, a net income of $3.7 million for the first half of 2026, and …

Lufax to Announce Second Quarter 2026 Financial Results on August 18, 2026

Lufax Holding Ltd (LU, 6623) announced it will release its second-quarter 2026 financial results after market close on Tuesday, August 18, 2026, U.S. Eastern Time. The company will host an earnings conference call on the same day at 9:00 P.M. U.S. Eastern Time (9:00 …

Full Transcript: AVAX One Technology Q2 2026 Earnings Call

CarMax Inc. stock outperforms competitors on strong trading day

CarMax Inc. (KMX) saw its stock advance by 2.28% to $60.05 on Thursday, outperforming the broader market. This gain occurred during a strong trading session where the S&P 500 Index rose 0.65% and the Dow Jones Industrial Average increased by 0.13%. This marks the …

Axon Shares: Flock Privacy Criticism Creates $285 Million Competitive Opportunity

Flock Safety's recent privacy changes, including reducing data retention and implementing mandatory case codes, have opened a significant competitive opportunity for Axon Enterprise (NASDAQ:AXON) in the fixed license-plate camera market. While the immediate revenue potential from Flock's $285 million annual recurring revenue is small …

GLXY to BDT: Galaxy Digital Inc. • Robinhood Token Price in Bangladeshi Taka

The article provides the current price of Galaxy Digital Inc. • Robinhood Token (GLXY) in Bangladeshi Taka (BDT), which is ৳2,609.73. It details how to buy GLXY using BDT, including identifying exchanges, setting up a crypto wallet, and making the trade. The piece also …

Glazer Capital details 7.77% Axiom stake in AXIN Units (AXIN)

Glazer Capital, LLC and Paul J. Glazer have reported a beneficial ownership of 1,600,072 Units in Axiom Intelligence Acquisition Corp 1 (AXIN), representing 7.77% of the outstanding class. The filing specifies that all voting and dispositive power over these securities is shared, with no …

Newsmax Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:NMAX) 2026-08-13

Newsmax, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Operational Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

ITHAX Acquisition Corp III (ITHA) builds $234M trust balance and $3.7M income

Equifax $100M Settlement Marks Record Payout Over Credit Score Coding Glitch

Equifax has agreed to a $100 million settlement for a class action lawsuit, resolving claims that a coding error in spring 2022 led to inaccurate credit scores for millions of Americans. This nonreversionary settlement is considered the largest resolution ever under the Fair Credit …

Dodge & Cox reports 4.3% GSK plc (GSK) stake in Schedule 13G/A

Dodge & Cox, an investment manager, has reported a 4.3% beneficial ownership stake in GSK plc, as detailed in an Amendment No. 3 to Schedule 13G filing. The filing indicates that Dodge & Cox beneficially owns 76,864,040 Ordinary Shares and 48,197,514 American Depositary Shares, …

Axiom Intelligence (AXIN) inks Terra Quantum deal amid going concern warning

Axiom Intelligence Acquisition Corp 1 (AXIN) has reported total assets of $208.3 million as of June 30, 2026, and a net income of $2.27 million for the six months ended June 30, 2026, primarily from interest on trust investments. The SPAC has entered into …

Axiom Intelligence Acquisition Corp 1 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

MarketAxess (MKTX) director Emily Portney records 4,170-share gift transfers

MarketAxess Holdings Inc. director Emily Hope Portney reported two bona fide gift transactions involving 4,170 shares of common stock on August 12, 2026. One transaction involved the acquisition of 2,085 shares held directly, while another involved the disposition of 2,085 shares held indirectly "By …

AVAX One Technology (AVX) grows revenue to $5.3M but records $81.5M loss

AXT Inc 2026: Revenue $47.59M, EPS $0.17— 10-Q Summary

AXT Inc reported strong financial results for the quarter ended 2026, with revenue surging 164.8% year-over-year to $47.59 million and diluted EPS reaching $0.17. This growth was driven by increased demand for InP substrates, expanded materials sales, and new long-term supply agreements. The company …

AVAX One Reports Second Quarter 2026 Financial and Operating Results

Why Himax Technologies (HIMX) Is Up 13.0% After Strong Q2 Results And Upbeat Q3 Outlook

Himax Technologies reported strong Q2 2026 results with revenue of US$227.37 million and net income of US$19.88 million, driven by demand for automotive display driver ICs. The company also provided an upbeat Q3 2026 outlook, projecting revenue growth of 7%–11% quarter-over-quarter and profit of …

Earnings Flash (NMAX) Newsmax Inc. Reports Q2 Revenue $54.1M, vs. FactSet Est of $48.6M

CarMax (KMX) Stock Sees Modest Fair Value Lift After More Constructive Q1 Analyst Views

CarMax's (KMX) fair value estimate has increased from US$51.31 to US$54.85, following more constructive analyst views after its Q1 update. Several firms have lifted their ratings and price targets, seeing CarMax as an early-stage turnaround story with improved sales traction, price elasticity, and operational …

Daxor Corporation (NASDAQ:DXR) Short Interest Update

MFS Blended Research International Equity Fund's GSK PLC(LSE:GSK) Holding History

MFS Blended Research International Equity Fund holds 1.57 million shares of GSK PLC (LSE:GSK), valued at £39.86 million, representing 0.85% of their portfolio. The fund acquired these shares at an average price of £20.07, and based on the current price of £18.57, has an …

GXAI Stock Pops As Revenue Soars And Buyback Signals Confidence

Gaxos.ai Inc. (GXAI) stock surged by over 55% due to strong Q2 2026 revenue of $2.46M, a 1,337% year-over-year increase, and positive GAAP net income. The company has strategically shifted focus from gaming to AI and health platforms, supported by a $1M share repurchase …

AXSOME THERAPEUTICS, INC. : MIZUHO RAISES TARGET PRICE TO $316 FROM $306

Mizuho has increased its target price for Axsome Therapeutics, Inc. to $316, up from the previous $306. This adjustment indicates a positive outlook from the analyst firm regarding the biopharmaceutical company's future performance.